EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

Ri Han iD, Hongryul Yoon, Gahee Kim, Hyundo Lee, Yoonji Lee iD

Pharmaceuticals · 06.09.2023 · 16 (9) · 1259

DOI: 10.3390/ph16091259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.09.2023. Verfasst von Ri Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea. Die Arbeit wurde bisher 171-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Chung-Ang University, Chung-Ang University Graduate Research Scholarship in 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencedrug discoverymedicinal chemistrystructure-based drug design

Autor:innen und Institutionen

  • College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.

ORCID-Profile: Ri Han, Yoonji Lee

Förderung

  • National Research Foundation of Korea
  • Chung-Ang University
  • Chung-Ang University Graduate Research Scholarship in 2023

Zitieren

APA

Han, R., Yoon, H., Kim, G., Lee, H., & Lee, Y. (2023). Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery. Pharmaceuticals, 16(9), 1259. https://doi.org/10.3390/ph16091259

Vancouver

Han R, Yoon H, Kim G, Lee H, Lee Y. Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery. Pharmaceuticals. 2023;16(9):1259. doi:10.3390/ph16091259

BibTeX
@article{Han2023,
  author = {Han, Ri and Yoon, Hongryul and Kim, Gahee and Lee, Hyundo and Lee, Yoonji},
  title = {Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {9},
  pages = {1259},
  doi = {10.3390/ph16091259}
}
Kostenlos starten →